These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Incongruence between dominant commensal donor microbes in recipient feces post fecal transplant and response to anti-PD-1 immunotherapy. Koo H; Morrow CD BMC Microbiol; 2021 Sep; 21(1):251. PubMed ID: 34544375 [TBL] [Abstract][Full Text] [Related]
13. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report. Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460 [TBL] [Abstract][Full Text] [Related]
14. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes. Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Leung V; Vincent C; Edens TJ; Miller M; Manges AR Clin Infect Dis; 2018 Jan; 66(3):456-457. PubMed ID: 29020222 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956 [TBL] [Abstract][Full Text] [Related]
17. Recovery of the gut microbiome following fecal microbiota transplantation. Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885 [TBL] [Abstract][Full Text] [Related]
18. Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection. Ray A; Jones C Future Microbiol; 2016 May; 11():611-6. PubMed ID: 26986546 [TBL] [Abstract][Full Text] [Related]